Evidence map›Paper›PMID 26966554›Full record

ArticleRMD open2016

Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set.

Umut Kalyoncu, Alexis Ogdie, Willemina Campbell, Clifton O Bingham, Maarten de Wit, Dafna D Gladman, Philip Mease, Ingrid Steinkoenig, Vibeke Strand, Victoria G Riese and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RMD open, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Umut KalyoncuDivision of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Division of Rheumatology, Hacettepe University, Ankara, Turkey.
Alexis OgdieUniversity of Pennsylvania , Philadelphia, Pennsylvania , USA.
Willemina CampbellPatient Research Partner , Toronto, Ontario , Canada.
Clifton O BinghamDivision of Rheumatology , Johns Hopkins University , Baltimore, Maryland , USA.
Maarten de WitDepartment of Medical Humanities , Patient Research Partner, VU University Medical Centre , Amsterdam , The Netherlands.
Dafna D GladmanToronto Western Hospital, University of Toronto , Toronto, Ontario , Canada.
Philip MeaseSwedish Medical Center and University of Washington , Seattle, Washington , USA.
Ingrid SteinkoenigPatient Research Partner , Cleveland, Ohio , USA.
Vibeke StrandDivision of Immunology , Stanford University , Palo Alto, California , USA.
Victoria G RieseDivision of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; National Institutes of Health Library, Education Services Branch, Bethesda, Maryland, USA.
Ana-Maria OrbaiDivision of Rheumatology , Johns Hopkins University , Baltimore, Maryland , USA.

Funding

Identification of Early Psoriatic ArthritisK23AR063764 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI OGDIE, ALEXIS R. · 2013 to 2017
$751k
NIAMS NIH HHS K23 AR063764
6 · The paper itself

Abstract

The objectives of this systematic literature review (SLR) were to identify domains and outcome measures used in psoriatic arthritis (PsA) studies in the past 5 years, and to compare the measurement of the Outcome Measures in Rheumatology (OMERACT) 2006 PsA Core Domain Set in studies published in 2010-2015 vs those published in 2006-2010. We performed a systematic literature search in two databases, PubMed and Embase, to identify randomised controlled trials (RCTs) in PsA. We also identified PsA longitudinal observational studies (LOS). Three patient research partners provided input into study conception, and data collection and interpretation. We identified 41 studies representing 22 unique RCTs, 27 LOS and 12 registries. Across all studies, we identified 24 domains and 169 outcome measures. In addition to the PsA Core Domain Set (6 domains), the following domains were also assessed in more than 30% of RCTs: acute phase reactants, dactylitis, enthesitis, fatigue and work productivity. We identified a range of 1-15 outcome measures per domain with a mean (SD) of 7 (4.7) per domain. The complete PsA Core Domain Set was assessed in 59% of RCTs in 2010-2015 compared to 23.5% RCTs in 2006-2010. There has been increased measurement of the PsA Core Domain Set in RCTs and LOS in the past 5 years. Numerous additional outcomes were also measured. The PsA Core Domain Set needs an update to standardise PsA outcome assessments. This SLR will inform the development of an updated PsA Core Domain Set with patient research partner input.

Indexed as

Health services researchOutcomes researchPsoriatic Arthritis

Identifiers

PMID26966554
PMCPMC4780312

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.